The Lupus Foundation of America has announced this year’s winners of the Gina M. Finzi Memorial Student Summer Fellowship Program,…
Articles by Patricia Inacio, PhD
Kyverna Therapeutics is planning to launch a Phase 1/2 trial in Germany to test KYV-101, its investigational cell therapy…
The first patient has been enrolled in a Phase 1 clinical trial testing KYV-101, Kyverna Therapeutics’ candidate cell therapy…
Gracell Biotechnologies announced the launch of a Phase 1 clinical trial in China testing GC012F, its experimental dual FastCAR…
People with systemic lupus erythematosus (SLE) have a unique mix of bacteria on their tongue compared with healthy people,…
Adding Saphnelo (anifrolumab-fnia) to standard therapy in people with moderate to severe systemic lupus erythematosus (SLE) is linked to reaching…
Almost half of women with systemic lupus erythematosus (SLE) who underwent assisted reproductive therapy (ART) became pregnant, and 83.3% of…
Women with systemic lupus erythematosus (SLE) whose disease went into remission right before becoming pregnant show better outcomes in the…
When given on top of standard therapy, zetomipzomib led to clinically significant reductions in urine protein levels, a marker of…
The incidence of systemic lupus erythematosus (SLE) has increased in the U.S. the past four decades, a recent study shows.